Matt Hoffman

The ROPA-DOP trial showed that low-dose dopamine had an insignificant impact on patient renal function, nor a significant trend toward greater diuresis.

Scott Solomon, MD, and Alvin Chandra, MD, discuss the findings of the PARADIGM-HF and QoL trial, and sacubitril's effect on HF patients quality of life.

Lisa Rathman, MSN, of Lancaster General Hospital, discusses the benefits of subcutaneous furosemide in nursing homes and facilities outside the hospital.

Gregg Fonarow, MD; David Aguilar, MD; Rob Mentz, MD; and James Januzzi, MD, discuss the unexpected and exciting use of SGLT-2 inhibitors to treat heart failure.

Rob Mentz, MD, of Duke University Medical School, discusses the CANVAS trial and the pursuit of using SGLT-2 inhibitors to treat heart failure.

The reSET app is the first mobile medical application to treat substance use disorders.

The approval marks the first FDA-approved treatment for pulmonary arterial hypertension.

The drug, produced by Sanofi, was granted approval based on the physiochemical, non-clinical, and clinical similarity to another, already approved insulin lispro injection.

In a phase 2 trial, MDMA reduced PTSD in 68% of patients after a 12-months period.

Methamphetamine was found to be linked to hemorrhagic strokes in 80% of cases.

In just 9 days of limited fructose consumption, both liver fat concentration and de novo lipogensis decreased.

Liraglutide showed a 13% reduction in major adverse cardiovascular events, reduced cardiovascular morbidity by 22%, and any morbidity by 15%.

COPD-related deaths increased 11.6% since 1990, and cases increased 44.2% to 174.5 million.

Raj Maturi, MD, talks about the use of sirolimus in combination with aflibercept for patients with chronic AMD.

Rajeev Muni speaks about the 1-year results of a randomized trial comparing Pneumatic Retinopexy vs. Vitrectomy in the management of primary Rhegmatogenous Retinal Detachment.

A meta-analysis of 9 studies found that water-based exercise is an equal alternative for type 2 diabetics.

The valve is the first stented surgical aortic valve that is MRI-safe without restrictions and uses single, one-cut release to increase the ease of implantation.

Jared Huston, MD, discusses the development and application of a new neural tourniquet device in the field of surgery.